Skip to contents Skip to Global Navigation Menu
  • KDCA
  • Contact us
  • E-Submission

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS. pISSN: 2210-9099. eISSN: 2233-6052

Page Path

2
results for

"Uterine cervical neoplasms"

Article category

Keywords

Publication year

Authors

"Uterine cervical neoplasms"

Original Articles
Long-term trends and post-pandemic deviations in cervical cancer burden in South India, 1990–2023: a Global Burden of Disease 2023 study
Indra Sivakumar, Jeevarathinam Thirumalai, Anees Ahmed Farooq Mohammed
Received March 13, 2026  Accepted July 22, 2026  Published online August 26, 2026  
DOI: https://doi.org/10.24171/j.phrp.2026.0252    [Epub ahead of print]
Objectives
Cervical cancer remains a major public health challenge in India despite advances in prevention through human papillomavirus (HPV) vaccination and screening. Although national estimates indicate gradual declines, marked regional disparities persist, and coronavirus disease 2019–related disruptions may have affected recent disease trajectories. This study assessed long-term trends, post-pandemic deviations, and progress toward World Health Organization (WHO) elimination targets in South India.
Methods
This population-based observational analysis used Global Burden of Disease Study 2023 estimates for women aged 30–69 years in South India from 1990 to 2023. Pre-pandemic trends and counterfactual projections were evaluated, and age-standardized incidence rates (ASRs) were descriptively compared with the WHO elimination threshold of ≤4 cases per 100,000 woman-years.
Results
Age-standardized cervical cancer incidence and mortality declined until the early 2010s but remained above national and global rates. Thereafter, declines stagnated and reversed. In 2023, incidence ranged from 26.1 per 100,000 women in Kerala to 65.8 in Telangana; all states exceeded the WHO threshold based on these ASRs. Observed rates exceeded counterfactual projections, but uncertainty envelopes included zero for every location and outcome. Thus, the findings are consistent with possible post-pandemic disruption to cervical cancer services rather than statistically demonstrated excess burden, and this ecological comparison cannot establish causality. Disability-adjusted life-year rates were highest among women aged 50–69 years.
Conclusion
South India appears to have experienced a recent loss of momentum in cervical cancer control. Strengthening HPV vaccination coverage, expanding screening, and improving the resilience of cancer prevention services are essential for accelerating progress toward elimination targets.
  • 605 View
  • 16 Download
Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer
Nicholas Ryan, Sari Eka Pratiwi, Mardhia Mardhia, Ysrafil Ysrafil, Delima Fajar Liana, Mahyarudin Mahyarudin
Osong Public Health Res Perspect 2024;15(4):307-328.
Published online July 23, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0013
Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer
Objectives
This study aimed to identify the optimal protein construction for designing a multi-epitope vaccine with both prophylactic and therapeutic effects against cervical cancer, utilizing an immunoinformatics approach. The construction process involved using capsid epitopes L1 and L2, as well as oncoproteins E5, E6, and E7 from human papillomavirus (HPV) types 16 and 18.
Methods
An experimental in silico analysis with an immunoinformatics approach was used to develop 2 multi-epitope vaccine constructs (A and B). Further analysis was then conducted to compare the constructs and select the one with the highest potential against cervical cancer.
Results
This study produced 2 antigenic, non-allergenic, and nontoxic multi-epitope vaccine constructs (A and B), which exhibited the ideal physicochemical properties for a vaccine. Further analysis revealed that construct B effectively induced both cellular and humoral immune responses.
Conclusion
The multi-epitope vaccine construct B for HPV 16 and 18, designed for both prophylactic and therapeutic purposes, met the development criteria for a cervical cancer vaccine. However, these findings need to be validated through in vitro and in vivo experiments.

Citations

Citations to this article as recorded by  Crossref logo
  • In-silico design and evaluation of a novel mRNA vaccine against human bocavirus 1: A neglected viral pathogen
    Aleeza Rubab, Asifa Sarfraz, Muhammad Umer Khan, Khaled Fahmi Fawy, Mohibullah Shah
    Computers in Biology and Medicine.2026; 200: 111344.     CrossRef
  • Design of a Multi‐Epitope Vaccine Targeting α‐Synuclein for Parkinson's Disease Using Immunoinformatics Tools
    Tatiane Batista dos Santos, Helena de Almeida Cerqueira Kodel, Geniana da Silva Gomes, Tatiane de Oliveira Xavier Machado, Dalton Ferreira Matos, Rafael Junqueira Borges, Daniela Droppa‐Almeida, Margarete Zanardo Gomes
    Peptide Science.2026;[Epub]     CrossRef
  • In-silico design of a multi-epitope vaccine candidate against Strongyloides stercoralis
    Yanick Aqua Stong Tangan, G. Takop Nchanji, Eric Ndumu, Abey Blessings Ayuk, Kongnyu Brandon Ngala, Melvis Berinyuy Dulandzev, Ntang Emmaculate Yaah, Lahngong Methodius Shinyuy, Cabirou Mounchili Shintouo, Bernis Neneyoh Yengo, Andreen Egbe Enowkpen, Mary
    BMC Infectious Diseases.2026;[Epub]     CrossRef
  • The current landscape of therapeutic vaccination approaches for treatment of HPV-dependent malignancies
    Johanne Audouze-Chaud, Ann-Katrin Schlosser, Angelika B. Riemer
    npj Vaccines.2026;[Epub]     CrossRef
  • Design of Multi‐Epitope DIVA‐Compatible Vaccine Candidate Against Canine Parvovirus 2
    Shubham Sharma, Pratishtha Sharma, Ravindra Pal Mandar, Ram Kumar, Ashok Gaur, Mamta Gurjar, Rajesh Singathia, Braj Nandan Shringi, Sunita Choudhary, Amit Kumar Pandey
    Journal of Molecular Recognition.2026;[Epub]     CrossRef
  • A bioinformatics pipeline for the design of a SART3-targeted cancer vaccine with enhanced immunogenicity
    Zeynab Bayat, Faezeh Mahdian-Khoo, Lida Samie, Amir Taherkhani
    Genomics & Informatics.2026;[Epub]     CrossRef
  • Computational design of a novel chimeric multi-epitope vaccine against chlamydia trachomatis serovar a to prevent trachoma
    Muhammad Irsyad Amien, Bimanda Rizki Nurhidayat, Siti Ulfatur Rizqa, Siti Zahra Arfiani, Latiefah Noer Widiastuti, Galuh Prasasti Isbach
    Brazilian Journal of Microbiology.2026;[Epub]     CrossRef
  • Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer
    Elvin Delonio, Ysrafil Ysrafil, Herlina Eka Shinta, Sari Eka Pratiwi
    Journal of the Egyptian National Cancer Institute.2026;[Epub]     CrossRef
  • Immunoinformatics Approach to Develop a Novel Chimeric L1/L2 Messenger RNA-based Vaccine Targeting a Broad Spectrum of Human Papillomavirus Species
    Nshimiyimana Sylvere, James Kimotho, Caroline Wangari Ngugi
    World's Veterinary Journal.2025; 15(2): 341.     CrossRef
  • Multi-epitope vaccine construct against Staphylococcus aureus : insights from immunoinformatics and molecular dynamics simulations
    K. Nachammai, P. Sangavi, K. Abishek, K. Langeswaran
    SAR and QSAR in Environmental Research.2025; 36(9): 795.     CrossRef
  • Designing a Multi-Epitope Vaccine Against HPV 16, 18, 33, and 45 Targeting L1 and E7 Proteins: An Immunoinformatics Approach for Cervical Cancer Prevention and Therapy
    Md. Touki Tahamid Tusar, Niamul Haq, Hafizur Rahman Gazi, Raduyan Farazi, Mamun Bhuya, Md. Enamul Haque, Md. Golzar Hossain, Abdullah-Al-Jubayer
    Bioinformatics and Biology Insights.2025;[Epub]     CrossRef
  • Modulation of epithelial homeostasis by HPV using Notch and Wnt
    June See Chong, John Doorbar
    Tumour Virus Research.2024; 18: 200297.     CrossRef
  • 8,051 View
  • 202 Download
  • 9 Web of Science
  • Crossref
Page of 1